Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics

被引:4
作者
Landskroner, K. A. [1 ]
Hess, P. [2 ]
Treiber, A. [1 ]
机构
[1] Actel Pharmaceut Ltd, Preclin Drug Metab & Pharmacokinet, CH-4123 Allschwil, Switzerland
[2] In Vivo Technol, Allschwil, Switzerland
关键词
Animal model; pharmacokinetics; ADME; drug discovery; EFFECTIVE DOSING REGIMEN; BILE-DUCT CANNULATION; IN-VITRO; ENTEROHEPATIC RECIRCULATION; XENOBIOTIC METABOLISM; ANTIPYRINE CLEARANCE; SPECIES-DIFFERENCES; CONSCIOUS DOGS; RAT; BLOOD;
D O I
10.3109/00498254.2011.569772
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mechanistic approaches in drug metabolism and pharmacokinetics during drug discovery depend upon animal models to increase the understanding of the absorption and disposition of new compounds. These animal models are also important to understand the complex interplay of biochemical and physiological events, and for the ability to answer questions in a reasonable time frame while interrogating numerous chemical structures. Many animal models have been described for understanding absorption, distribution, metabolism, and excretion and this review attempts to summarise some of these models. The focus is primarily on surgical and pharmacological models for pharmacokinetic studies in rodents with special emphasis on descriptive methodologies for researchers embarking on in vivo studies. In this review, the surgical approaches include the mechanical instrumentation of anatomical structures, e.g. abdominal cavity, marginal ear vein, while pharmacological models are restricted to chemical inhibition of the cytochrome P450 enzymes and P-gp to understand hepatic metabolism or brain penetration and intestinal absorption, respectively. The purpose of this review is not to exhaustively characterise each model but to serve as a general resource for investigators interested in performing these models.
引用
收藏
页码:687 / 700
页数:14
相关论文
共 62 条
[1]   The potential influence of CO2, as an agent for euthanasia, on the pharmacokinetics of basic compounds in rodents [J].
Angus, Derek W. ;
Baker, James A. ;
Mason, Rona ;
Martin, Iain J. .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) :375-379
[2]   PHARMACOKINETICS OF THE RECOMBINANT FUSION PROTEIN DAB486IL-2 IN ANIMAL-MODELS [J].
BACHA, P ;
FORTE, S ;
KASSAM, N ;
THOMAS, J ;
AKIYOSHI, D ;
WATERS, C ;
NICHOLS, J ;
ROSENBLUM, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (06) :409-414
[3]   Characterization of post-surgical alterations in the bile duct-cannulated rat [J].
Bachir-Cherif, Dalila ;
Blum, Denise ;
Braendli-Baiocco, Annamaria ;
Chaput, Evelyne ;
Pacheco, Gonzalo Christiano Duran ;
Flint, Nicholas ;
Haiker, Monika ;
Hoflack, Jean-Christophe ;
Justies, Nicole ;
Neff, Rachel ;
Starke, Volkmar ;
Steiner, Guido ;
Tournillac, Charles Alexandre ;
Singer, Thomas ;
Ubeaud-Sequier, Genevieve ;
Schuler, Franz .
XENOBIOTICA, 2011, 41 (08) :701-711
[4]   Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling [J].
Balani, SK ;
Li, P ;
Nguyen, J ;
Cardoza, K ;
Zeng, H ;
Mu, DX ;
Wu, JT ;
Gan, LS ;
Lee, FW .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (10) :1092-1095
[5]   Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys [J].
Balani, SK ;
Zhu, T ;
Yang, TJ ;
Liu, Z ;
He, B ;
Lee, FW .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (10) :1059-1062
[6]   The isolated perfused rat liver: standardization of a time-honoured model [J].
Bessems, M. ;
t'Hart, N. A. ;
Tolba, R. ;
Doorschodt, B. M. ;
D Leuvenink, H. G. ;
Ploeg, R. J. ;
Minor, T. ;
van Gulik, T. M. .
LABORATORY ANIMALS, 2006, 40 (03) :236-246
[7]   Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man [J].
Bogaards, JJP ;
Bertrand, M ;
Jackson, P ;
Oudshoorn, MJ ;
Weaver, RJ ;
van Bladeren, PJ ;
Walther, B .
XENOBIOTICA, 2000, 30 (12) :1131-1152
[8]  
Boyd Michael, 2004, Journal of Pharmacological and Toxicological Methods, V49, P115, DOI 10.1016/j.vascn.2003.11.004
[9]   TRANSPORT OF LIPOPHILIC MOLECULES BY THE INTESTINAL LYMPHATIC-SYSTEM [J].
CHARMAN, WN ;
STELLA, VJ .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 7 (01) :1-14
[10]   Minimizing the immunogenicity of protein therapeutics [J].
Chirino, AJ ;
Ary, ML ;
Marshall, SA .
DRUG DISCOVERY TODAY, 2004, 9 (02) :82-90